Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AMN Healthcare Services filings document operating results, governance matters, capital-structure disclosures, and material events for a healthcare workforce solutions company. Form 8-K reports include quarterly and annual financial results, Regulation FD investor presentation materials, board and officer matters, and amendments to corporate bylaws.
The company's proxy materials cover annual meeting voting, board composition, shareholder proposal procedures, director nomination mechanics, governance practices, performance discussion, and capital allocation priorities. Filings also disclose segment activity across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions, along with debt, leverage, liquidity, and risk-related reporting.
AMN Healthcare Services, Inc. announced that longtime director R. Jeffrey Harris plans to retire from its Board at the company’s 2026 annual meeting of shareholders and will not stand for re-election. The Board intends to nominate Eric Palmer, a veteran healthcare and insurance executive with more than 25 years of leadership experience, including senior roles at The Cigna Group and Evernorth Health Services, to stand for election at that meeting.
The Vanguard Group filed an amended Schedule 13G reporting a significant passive stake in AMN Healthcare Services Inc. Vanguard reports beneficial ownership of 3,634,998 shares of AMN common stock, representing 9.46% of the class as of the event date.
Vanguard reports shared voting power over 334,280 shares and shared dispositive power over all 3,634,998 shares, with no sole voting or dispositive power. The filing states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. Vanguard also notes an internal realignment on January 12, 2026, after which certain subsidiaries are expected to report beneficial ownership separately while pursuing the same investment strategies.
AMN Healthcare Services chief information and digital officer Mark C. Hagan reported multiple equity compensation transactions on common stock and restricted stock units. On January 15, 2026, several blocks of restricted stock units vested and converted into AMN common shares, with related shares withheld to cover taxes at $19.55 per share.
Following these transactions, Hagan directly owned 44,873 shares of AMN common stock and 36,828 restricted stock units. The filing also records a new grant of 36,828 restricted stock units under the AMN Healthcare 2025 Equity Plan, vesting in three annual tranches. An earlier filing was corrected, reducing the previously reported derivative holdings from 73,656 units to 36,828 units due to an administrative error.
AMN Healthcare Services’ CFO/COO, Brian M. Scott, filed an amended Form 4 to update his equity holdings after January 15, 2026 transactions. The filing shows 8,843 Restricted Stock Units vested into common stock, with 3,592 shares withheld at $19.55 per share for taxes, leaving 13,093 common shares held directly.
After these transactions, he holds 17,956 Restricted Stock Units from a 2025 grant and 40,920 Restricted Stock Units from a new January 15, 2026 grant, each unit representing one share of AMN common stock. The amendment corrects a prior overstatement, clarifying that 40,920, not 81,840, derivative securities were beneficially owned following the reported transaction.
AMN Healthcare’s Chief Legal Officer reported several equity award movements on AMN common stock. On January 15, 2026, restricted stock units vested into common shares, and some shares were withheld at $19.55 per share to cover taxes, leaving 23,652 common shares beneficially owned directly.
The filing also shows activity in restricted stock units. Earlier RSU awards vested into common stock, reducing those RSU balances, while a new grant of 19,641 RSUs was received under the AMN Healthcare 2025 Equity Plan, resulting in 19,641 derivative securities beneficially owned. The amendment corrects a prior filing that had overstated RSU holdings by 19,641 units, clarifying that the correct post‑transaction balance is 19,641, not 39,282.
AMN Healthcare Services CEO Caroline Grace reported multiple equity compensation transactions dated January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were settled into AMN common stock in amounts of 5,042, 10,664, and 25,425 shares, with corresponding common stock entries showing these as acquisitions at $0 per share. The filing notes that these common shares were acquired upon RSU vesting and that some shares, including 1,495, 2,713, and 6,191 shares at $19.55 per share, were withheld to cover taxes.
After the reported transactions, Grace directly beneficially owned 81,686 shares of AMN common stock, which includes 607 shares acquired through the employee stock purchase plan. She also received a new RSU grant covering 129,923 units, all directly held, each representing a contingent right to one share of common stock and vesting in three annual tranches beginning on the grant date.
AMN Healthcare Services Inc. Chief Legal Officer Whitney M. Laughlin reported equity award activity dated January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into shares of AMN common stock, with portions of the resulting shares withheld to cover taxes at a price of $19.55 per share.
The filing shows RSU conversions of 202, 749 and 3,537 units into common stock, paired with tax withholdings of 60, 223 and 1,049 shares, respectively. Following these transactions, Laughlin held 23,652 shares of AMN common stock directly.
On the same date, Laughlin received a new grant of 19,641 RSUs under the AMN Healthcare 2025 Equity Plan, each unit representing a right to receive one share of common stock. After this grant, Laughlin beneficially owned 39,282 RSUs, which vest in three annual tranches starting from their respective grant dates.
AMN Healthcare Services executive Mark Christopher Hagan, Chief Information and Digital officer, reported multiple equity compensation transactions on January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into common stock, including 1,433, 2,248, and 6,632 shares of AMN common stock. To cover taxes, the company withheld 591, 926, and 2,622 shares at a price of $19.55 per share.
On the same date, Hagan received a new grant of 36,828 RSUs under the AMN Healthcare 2025 Equity Plan, each representing a right to one share of common stock. After these transactions, he directly owned 44,873 shares of AMN common stock and held 73,656 RSUs. The RSUs granted on January 15 of 2023, 2024, 2025, and 2026 all vest in three annual tranches tied to continued service.
AMN Healthcare Services CFO/COO Brian M. Scott reported equity compensation activity on January 15, 2026. He acquired 8,843 shares of common stock at $0 upon vesting of Restricted Stock Units and then had 3,592 shares of common stock withheld at $19.55 per share to cover taxes, leaving him with 13,093 shares of common stock held directly.
On the derivative side, 8,843 Restricted Stock Units were converted into common stock, after which he held 17,956 Restricted Stock Units from an award granted under the AMN Healthcare 2017 Equity Plan that vests over three years. He also received a new grant of 40,920 Restricted Stock Units under the AMN Healthcare 2025 Equity Plan, bringing his total Restricted Stock Units to 81,840, each representing a contingent right to one share of AMN common stock and vesting in three annual tranches.
AMN Healthcare Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026. The company has prepared a slide presentation for this event, which is attached as Exhibit 99.1 and will also be available through the Investor Relations section of its website at https://ir.amnhealthcare.com/.
The information related to this conference appearance is being furnished under Item 7.01 and is not deemed filed under securities laws, meaning it will only be incorporated into other documents by specific reference. The report is signed on behalf of the company by Chief Executive Officer Cary Grace.